Hoth Therapeutics Stock Probability of Future Stock Price Finishing Over 1.17

HOTH Stock  USD 1.17  0.02  1.68%   
Hoth Therapeutics' future price is the expected price of Hoth Therapeutics instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Hoth Therapeutics performance during a given time horizon utilizing its historical volatility. Check out Hoth Therapeutics Backtesting, Hoth Therapeutics Valuation, Hoth Therapeutics Correlation, Hoth Therapeutics Hype Analysis, Hoth Therapeutics Volatility, Hoth Therapeutics History as well as Hoth Therapeutics Performance.
For more detail on how to invest in Hoth Stock please use our How to Invest in Hoth Therapeutics guide.
  
The current Price Earnings Ratio is estimated to decrease to -0.66. The current Price Book Value Ratio is estimated to decrease to 0.53. Please specify Hoth Therapeutics' target price for which you would like Hoth Therapeutics odds to be computed.

Hoth Therapeutics Target Price Odds to finish over 1.17

The tendency of Hoth Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 1.17 90 days 1.17 
more than 94.0
Based on a normal probability distribution, the odds of Hoth Therapeutics to move above the current price in 90 days from now is more than 94.0 (This Hoth Therapeutics probability density function shows the probability of Hoth Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.16 . This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Hoth Therapeutics will likely underperform. Additionally Hoth Therapeutics has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
   Hoth Therapeutics Price Density   
       Price  

Predictive Modules for Hoth Therapeutics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Hoth Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Hoth Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.061.175.85
Details
Intrinsic
Valuation
LowRealHigh
0.112.186.86
Details
Naive
Forecast
LowNextHigh
0.021.185.86
Details
2 Analysts
Consensus
LowTargetHigh
4.785.255.83
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Hoth Therapeutics. Your research has to be compared to or analyzed against Hoth Therapeutics' peers to derive any actionable benefits. When done correctly, Hoth Therapeutics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Hoth Therapeutics.

Hoth Therapeutics Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Hoth Therapeutics is not an exception. The market had few large corrections towards the Hoth Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Hoth Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Hoth Therapeutics within the framework of very fundamental risk indicators.
α
Alpha over NYSE Composite
-0.13
β
Beta against NYSE Composite1.16
σ
Overall volatility
0.1
Ir
Information ratio -0.02

Hoth Therapeutics Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Hoth Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Hoth Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Hoth Therapeutics generated a negative expected return over the last 90 days
Hoth Therapeutics may become a speculative penny stock
Hoth Therapeutics has high historical volatility and very poor performance
Net Loss for the year was (7.85 M) with profit before overhead, payroll, taxes, and interest of 0.
Hoth Therapeutics currently holds about 11.62 M in cash with (8.45 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.02, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Hoth Therapeutics has a frail financial position based on the latest SEC disclosures
Latest headline from gizmodo.com: These Star Wars Toy Photos Are as Special as the Toys Themselves

Hoth Therapeutics Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Hoth Stock often depends not only on the future outlook of the current and potential Hoth Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Hoth Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding3.4 M
Cash And Short Term Investments9.3 M

Hoth Therapeutics Technical Analysis

Hoth Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Hoth Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Hoth Therapeutics. In general, you should focus on analyzing Hoth Stock price patterns and their correlations with different microeconomic environments and drivers.

Hoth Therapeutics Predictive Forecast Models

Hoth Therapeutics' time-series forecasting models is one of many Hoth Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Hoth Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Hoth Therapeutics

Checking the ongoing alerts about Hoth Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Hoth Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Hoth Therapeutics generated a negative expected return over the last 90 days
Hoth Therapeutics may become a speculative penny stock
Hoth Therapeutics has high historical volatility and very poor performance
Net Loss for the year was (7.85 M) with profit before overhead, payroll, taxes, and interest of 0.
Hoth Therapeutics currently holds about 11.62 M in cash with (8.45 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.02, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Hoth Therapeutics has a frail financial position based on the latest SEC disclosures
Latest headline from gizmodo.com: These Star Wars Toy Photos Are as Special as the Toys Themselves
When determining whether Hoth Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Hoth Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Hoth Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Hoth Therapeutics Stock:

Complementary Tools for Hoth Stock analysis

When running Hoth Therapeutics' price analysis, check to measure Hoth Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hoth Therapeutics is operating at the current time. Most of Hoth Therapeutics' value examination focuses on studying past and present price action to predict the probability of Hoth Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hoth Therapeutics' price. Additionally, you may evaluate how the addition of Hoth Therapeutics to your portfolios can decrease your overall portfolio volatility.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Fundamental Analysis
View fundamental data based on most recent published financial statements
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Is Hoth Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hoth Therapeutics. If investors know Hoth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hoth Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.30)
Return On Assets
(0.59)
Return On Equity
(1.13)
The market value of Hoth Therapeutics is measured differently than its book value, which is the value of Hoth that is recorded on the company's balance sheet. Investors also form their own opinion of Hoth Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Hoth Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hoth Therapeutics' market value can be influenced by many factors that don't directly affect Hoth Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hoth Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Hoth Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hoth Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.